Atopic Dermatitis
Article
Antibiotic use in infancy may increase the risk of developing atopic dermatitis
Article
More severe atopic dermatitis tied with poor sleep health and attention dysregulation
Article
Atopic dermatitis may precede the onset of delinquent behaviors in children and adolescents
Article
Patients with atopic dermatitis at higher risk for COVID-19 infection
Article
Atopic dermatitis: Patients showing suboptimal response to initial dupilumab may benefit from long-term treatment
Article
Upadacitinib and topical corticosteroids combo safe in mild-to-moderate atopic dermatitis
Article
GlcChol levels and GBA activity could serve as biomarkers of therapeutic response in atopic dermatitis
Article
Atopic dermatitis not associated with low bone mineral density in young adults
Article
Atopic dermatitis: Rapid and sustained disease control with dupilumab
News from the FDA/CDC
FDA approves two JAK-1 inhibitors for moderate to severe atopic dermatitis
“It’s big news because a few years ago we didn’t have any systemic treatments that are safer than the classical immunosuppressants.”